{"id":"https://openalex.org/W2592033002","doi":"https://doi.org/10.1002/syn.21967","title":"Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate","display_name":"Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate","alternate_titles":[],"publication_year":2017,"publication_date":"2017-03-17","ids":{"openalex":"https://openalex.org/W2592033002","doi":"https://doi.org/10.1002/syn.21967","mag":"2592033002","pmid":"https://pubmed.ncbi.nlm.nih.gov/28295625","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5485051"},"language":"en","primary_location":{"id":"doi:10.1002/syn.21967","doi":"https://doi.org/10.1002/syn.21967","is_oa":true,"landing_page_url":"https://doi.org/10.1002/syn.21967","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/syn.21967","source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2592033002"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/syn.21967","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034980545","display_name":"Anna Migdalska\u2010Richards","orcid":"https://orcid.org/0000-0001-6992-0751","observed_orcids":["https://orcid.org/0000-0001-6992-0751"]},"institutions":[{"id":"https://openalex.org/I4405260083","display_name":"UCL Queen Square Institute of Neurology","ror":"https://ror.org/0370htr03","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405260083","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna Migdalska\u2010Richards","raw_affiliation_strings":["Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF United Kingdom","institution_ids":["https://openalex.org/I4405260083","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032345649","display_name":"Wai Kin D. Ko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138732","display_name":"Motac Neuroscience (United Kingdom)","ror":"https://ror.org/04pc38187","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210138732"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wai Kin D. Ko","raw_affiliation_strings":["Motac Neuroscience, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Motac Neuroscience, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210138732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100438915","display_name":"Qin Li","orcid":"https://orcid.org/0000-0002-6315-4678","observed_orcids":["https://orcid.org/0000-0002-6315-4678"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210131085","display_name":"Institute of Laboratory Animal Science","ror":"https://ror.org/038z7hb11","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210131085","https://openalex.org/I4210141683"]},{"id":"https://openalex.org/I4210138732","display_name":"Motac Neuroscience (United Kingdom)","ror":"https://ror.org/04pc38187","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210138732"]}],"countries":["CN","GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Qin Li","raw_affiliation_strings":["Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China","Motac Neuroscience, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210131085"]},{"raw_affiliation_string":"Motac Neuroscience, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210138732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004190849","display_name":"Erwan B\u00e9zard","orcid":"https://orcid.org/0000-0002-0410-4638","observed_orcids":["https://orcid.org/0000-0002-0410-4638"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210087077","display_name":"Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives","ror":"https://ror.org/001695n52","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I15057530","https://openalex.org/I154526488","https://openalex.org/I3018323443","https://openalex.org/I4210087077","https://openalex.org/I4210096427"]},{"id":"https://openalex.org/I4210131085","display_name":"Institute of Laboratory Animal Science","ror":"https://ror.org/038z7hb11","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210131085","https://openalex.org/I4210141683"]},{"id":"https://openalex.org/I4210138732","display_name":"Motac Neuroscience (United Kingdom)","ror":"https://ror.org/04pc38187","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210138732"]}],"countries":["CN","FR","GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Erwan Bezard","raw_affiliation_strings":["CNRS, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293 Bordeaux F\u201033000 France","Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China","Motac Neuroscience, Manchester, United Kingdom","University de Bordeaux, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293 Bordeaux F\u201033000 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293 Bordeaux F\u201033000 France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210087077"]},{"raw_affiliation_string":"Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210131085"]},{"raw_affiliation_string":"Motac Neuroscience, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210138732"]},{"raw_affiliation_string":"University de Bordeaux, Institut des Maladies Neurod\u00e9g\u00e9n\u00e9ratives, UMR 5293 Bordeaux F\u201033000 France","institution_ids":["https://openalex.org/I4210087077"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059770430","display_name":"Anthony H.V. Schapira","orcid":"https://orcid.org/0000-0002-3018-3966","observed_orcids":["https://orcid.org/0000-0002-3018-3966"]},"institutions":[{"id":"https://openalex.org/I4405260083","display_name":"UCL Queen Square Institute of Neurology","ror":"https://ror.org/0370htr03","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405260083","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anthony H. V. Schapira","raw_affiliation_strings":["Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-3018-3966","affiliations":[{"raw_affiliation_string":"Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF United Kingdom","institution_ids":["https://openalex.org/I4405260083","https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5059770430"],"corresponding_institution_ids":["https://openalex.org/I4405260083","https://openalex.org/I45129253"],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":{"value":1716,"currency":"EUR","value_usd":1850},"fwci":10.7802,"has_fulltext":true,"cited_by_count":130,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98998446,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"71","issue":"7","first_page":"e21967","last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ambroxol","display_name":"ambroxol","score":1.0},{"id":"https://openalex.org/keywords/glucocerebrosidase","display_name":"glucocerebrosidase","score":0.9850000143051147},{"id":"https://openalex.org/keywords/gba1","display_name":"GBA1","score":0.8569999933242798},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.890999972820282},{"id":"https://openalex.org/keywords/gaucher-disease","display_name":"Gaucher disease","score":0.9509999752044678},{"id":"https://openalex.org/keywords/neuronopathic-gaucher-disease","display_name":"neuronopathic Gaucher disease","score":0.9110000133514404},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.8980000019073486},{"id":"https://openalex.org/keywords/alpha-synuclein","display_name":"alpha-synuclein","score":0.8970000147819519},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.7300000190734863},{"id":"https://openalex.org/keywords/enzyme-activity","display_name":"enzyme activity","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2780674200","wikidata":"https://www.wikidata.org/wiki/Q420038","display_name":"Glucocerebrosidase","level":3,"score":0.9296200275421143},{"id":"https://openalex.org/C2776330663","wikidata":"https://www.wikidata.org/wiki/Q221637","display_name":"Ambroxol","level":2,"score":0.9152724742889404},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.5047627687454224},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4932660460472107},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4405449628829956},{"id":"https://openalex.org/C2781449126","wikidata":"https://www.wikidata.org/wiki/Q288591","display_name":"Alpha-synuclein","level":4,"score":0.4373292326927185},{"id":"https://openalex.org/C3018809729","wikidata":"https://www.wikidata.org/wiki/Q7380","display_name":"Nonhuman primate","level":2,"score":0.4322279095649719},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3574223220348358},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3449089527130127},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.31267204880714417},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.309256911277771},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23460695147514343},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21298527717590332},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.09594103693962097},{"id":"https://openalex.org/C78458016","wikidata":"https://www.wikidata.org/wiki/Q840400","display_name":"Evolutionary biology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074286","descriptor_name":"Preliminary Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000551","descriptor_name":"Ambroxol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005962","descriptor_name":"Glucosylceramidase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054821","descriptor_name":"beta-Hexosaminidase beta Chain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1002/syn.21967","doi":"https://doi.org/10.1002/syn.21967","is_oa":true,"landing_page_url":"https://doi.org/10.1002/syn.21967","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/syn.21967","source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5485051","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5485051/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"Text"},{"id":"pmid:28295625","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28295625","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse (New York, N.Y.)","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-01537217v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-01537217","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Synapse, 2017, 71 (7), &#x27E8;10.1002/syn.21967&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1555086","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1555086/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Synapse (2017)","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1002/syn.21967","doi":"https://doi.org/10.1002/syn.21967","is_oa":true,"landing_page_url":"https://doi.org/10.1002/syn.21967","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/syn.21967","source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G241998845","display_name":null,"funder_award_id":"G1403","funder_id":"https://openalex.org/F4320320021","funder_display_name":"Parkinson's UK"},{"id":"https://openalex.org/G4175593469","display_name":"Targeting glucocerebrosidase for disease-modifying treatments in Parkinson's disease","funder_award_id":"MR/L501499/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G5139107751","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0611-10237","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G8150040937","display_name":"Glucocerebrosidase mutations in Parkinson disease:molecular pathogenesis,and the basis for personalised therapy with small molecule chaperones","funder_award_id":"MR/M006646/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320021","display_name":"Parkinson's UK","ror":"https://ror.org/02417p338"},{"id":"https://openalex.org/F4320320286","display_name":"University College London","ror":"https://ror.org/02jx3x895"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2592033002.pdf","grobid_xml":"https://content.openalex.org/works/W2592033002.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1967348306","https://openalex.org/W1987490764","https://openalex.org/W1996637092","https://openalex.org/W2017411361","https://openalex.org/W2021567923","https://openalex.org/W2072352693","https://openalex.org/W2096739914","https://openalex.org/W2133712961","https://openalex.org/W2134369114","https://openalex.org/W2170281382","https://openalex.org/W2337871602","https://openalex.org/W2553724719"],"related_works":["https://openalex.org/W2553724719","https://openalex.org/W2998953100","https://openalex.org/W3128898550","https://openalex.org/W889893070","https://openalex.org/W4398765991","https://openalex.org/W7214447528","https://openalex.org/W4396541360","https://openalex.org/W4398781462","https://openalex.org/W2883075662"],"abstract_inverted_index":{"Mutations":[0],"in":[1,45,73,85,109],"the":[2,21,30,49,65],"glucocerebrosidase":[3,28],"1":[4],"(GBA1)":[5],"gene":[6],"are":[7],"related":[8],"to":[9,47],"both":[10,19,104],"Parkinson":[11],"disease":[12,16],"(PD)":[13],"and":[14,55,106],"Gaucher":[15],"(GD).":[17],"In":[18,60],"cases,":[20],"condition":[22],"is":[23,36],"associated":[24],"with":[25],"deficiency":[26],"of":[27,67,82],"(GCase),":[29],"enzyme":[31],"encoded":[32],"by":[33],"GBA1.":[34],"Ambroxol":[35],"a":[37,100],"small":[38],"molecule":[39],"chaperone":[40],"that":[41,79,94],"has":[42],"been":[43],"shown":[44],"mice":[46],"cross":[48],"blood-brain":[50],"barrier,":[51],"increase":[52],"GCase":[53,71,88],"activity":[54,72],"reduce":[56],"alpha-synuclein":[57],"protein":[58],"levels.":[59],"this":[61],"study,":[62],"we":[63],"analyze":[64],"effect":[66],"ambroxol":[68,83,95],"treatment":[69],"on":[70],"healthy":[74],"nonhuman":[75],"primates.":[76],"We":[77],"show":[78],"daily":[80],"administration":[81],"results":[84],"increased":[86],"brain":[87],"activity.":[89],"Our":[90],"work":[91],"further":[92],"indicates":[93],"should":[96],"be":[97],"investigated":[98],"as":[99],"novel":[101],"therapy":[102],"for":[103],"PD":[105],"neuronopathic":[107],"GD":[108],"humans.":[110]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2592033002","counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2017-03-16T00:00:00"}
